Abstract
Cardiac diseases remain the leading cause of morbidity and mortality worldwide. Heart functions are regulated by autonomic nervous systems through their transmitters and modulators, binding to cell surface receptors. Among them, the cardiac M3 muscarinic acetylcholine receptor (M3-mAChR) has been studied for more than 2 decades since its first discovery in mammalian heart in 1990s. The location and pathophysiological role of M3-mAChR in the cardiovascular system have been extensively studied and many pathways involved have been uncovered. Gain- and loss-of-function studies have revealed the ubiquitous roles of M3-mAChR in physiological and pathological conditions. Recently, many new findings have been uncovered about the relationship between M3-mAChR and cardiac diseases, including cardiac ischemia, pathological cardiac hypertrophy, cardiac arrhythmias, cardiac conduction and heart failure. Furthermore, the novel potential cardioprotective role of M3-mAChR against heart injury by regulation of microRNAs (miRNAs) has been revealed in the most updated research. In this review, the current new findings on the role of M3-mAChR in heart diseases are updated, the downstream signaling pathways are summarized, perspectives and challenges of M3-mAChR as therapeutic targets are discussed.
Keywords: Cardiac disease, M3 muscarinic acetylcholine receptor, microRNAs, MYOCARDIAL Ischemia, CARDIAC hypertrophy, autonomic nervous systems
Current Drug Targets
Title:Novel Insights into the Pervasive Role of M3 Muscarinic Receptor in Cardiac Diseases
Volume: 14 Issue: 3
Author(s): Pengzhou Hang, Jing Zhao, Jiancui Qi, Yan Wang, Jianwei Wu and Zhimin Du
Affiliation:
Keywords: Cardiac disease, M3 muscarinic acetylcholine receptor, microRNAs, MYOCARDIAL Ischemia, CARDIAC hypertrophy, autonomic nervous systems
Abstract: Cardiac diseases remain the leading cause of morbidity and mortality worldwide. Heart functions are regulated by autonomic nervous systems through their transmitters and modulators, binding to cell surface receptors. Among them, the cardiac M3 muscarinic acetylcholine receptor (M3-mAChR) has been studied for more than 2 decades since its first discovery in mammalian heart in 1990s. The location and pathophysiological role of M3-mAChR in the cardiovascular system have been extensively studied and many pathways involved have been uncovered. Gain- and loss-of-function studies have revealed the ubiquitous roles of M3-mAChR in physiological and pathological conditions. Recently, many new findings have been uncovered about the relationship between M3-mAChR and cardiac diseases, including cardiac ischemia, pathological cardiac hypertrophy, cardiac arrhythmias, cardiac conduction and heart failure. Furthermore, the novel potential cardioprotective role of M3-mAChR against heart injury by regulation of microRNAs (miRNAs) has been revealed in the most updated research. In this review, the current new findings on the role of M3-mAChR in heart diseases are updated, the downstream signaling pathways are summarized, perspectives and challenges of M3-mAChR as therapeutic targets are discussed.
Export Options
About this article
Cite this article as:
Hang Pengzhou, Zhao Jing, Qi Jiancui, Wang Yan, Wu Jianwei and Du Zhimin, Novel Insights into the Pervasive Role of M3 Muscarinic Receptor in Cardiac Diseases, Current Drug Targets 2013; 14 (3) . https://dx.doi.org/10.2174/1389450111314030009
DOI https://dx.doi.org/10.2174/1389450111314030009 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
QT Alterations in Psychopharmacology: Proven Candidates and Suspects
Current Drug Safety The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Current Drug Safety New Approaches for the Treatment of Chagas Disease
Current Drug Targets Ryanodine Receptor Patents
Recent Patents on Biotechnology Concise Review of the Rationale for Pulmonary Embolism Treatment and Endovascular Device Therapies
Current Cardiology Reviews Rasburicase: A New Approach for Preventing and/or Treating Tumor Lysis Syndrome
Current Pharmaceutical Design Pharmacotherapy of Abdominal Aortic Aneurysms
Current Vascular Pharmacology Is Peri-Operative Isolated Systolic Hypertension (ISH) a Cardiac Risk Factor?
Current Cardiology Reviews Drug-Induced Hypothermia in Stroke Models: Does it Always Protect?
CNS & Neurological Disorders - Drug Targets Myocardial Ischemia/Reperfusion Injury: Potential of TRPV1 Agonists as Cardioprotective Agents
Cardiovascular & Hematological Disorders-Drug Targets The Treatment of Behavioral and Psychological Symptoms of Dementia: Weighing Benefits and Risks
Current Alzheimer Research Delivery Systems of Opioid Analgesics for Pain Relief: A Review
Current Pharmaceutical Design Late Sodium Current Inhibition: The Most Promising Antiarrhythmic Principle in the Near Future?
Current Medicinal Chemistry Study of Prolactin Permeation Through the Pericardium and Its Bioavailability
Protein & Peptide Letters Recent Advances in Image-Based Stem-Cell Labeling and Tracking, and Scaffold-Based Organ Development in Cardiovascular Disease
Recent Patents on Medical Imaging Toll-like Receptor 4 Mediates LPS-Induced Release of Nitric Oxide and Tumor Necrosis Factor-α by Embryonal Cardiomyocytes: Biological Significance and Clinical Implications in Human Pathology
Current Pharmaceutical Design Mechanisms of Protective Effects of SGLT2 Inhibitors in Cardiovascular Disease and Renal Dysfunction
Current Topics in Medicinal Chemistry Antidepressants: Update on Benefits and Risks
Current Psychopharmacology COVID-19, Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Inhibition: Implications for Practice
Current Hypertension Reviews Herbal and Traditional Chinese Medicine for the Treatment of Cardiovascular Complications in Diabetes Mellitus
Current Diabetes Reviews